Crazy returns extraction (2026-05-20)
Top declarations sorted by BacktestResult.returnFromPub90d >= 200%. Cohort: BUY only. 50 qualifying rows.
Common characteristics
Role: OTHER=40 (80%), CEO=4 (8%), BOARD=3 (6%), CFO=3 (6%)
Market: XNAS=16 (32%), XTKS=12 (24%), XPAR=10 (20%), XBOM=6 (12%), XSTO=4 (8%), XMAD=2 (4%)
Sector: NA=30 (60%), Technologie=11 (22%), Santé & Pharma=9 (18%)
Kind (rel): direct=50 (100%)
Cluster: SOLO=50 (100%)
Market cap bucket: MID=35 (70%), MICRO=7 (14%), SMALL=4 (8%), LARGE=3 (6%), NA=1 (2%)
Top 50 declarations
| rank | r90% | pubDate | company | market | sector | role | name | kind | cluster | pctMcap | amount EUR | mcap |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 126972 | 2025-01-28 | DISTRIBUIDORA INTERNACIONAL DE ALIMENTACIÓN, S.A. | XMAD | - | OTHER | SERGIO FERREIRA DIAS | direct | SOLO | 0.00 | 76 923 | 2251M |
| 2 | 116068 | 2024-12-19 | DISTRIBUIDORA INTERNACIONAL DE ALIMENTACIÓN, S.A. | XMAD | - | OTHER | LUISA DEPLAZES DE ANDRADE DELGADO | direct | SOLO | 0.00 | 73 077 | 2251M |
| 3 | 1650 | 2022-05-02 | Nuo Therapeutics, Inc. | XNAS | - | OTHER | SHEEDY CHARLES E | direct | SOLO | 1.27 | 766 234 | 60M |
| 4 | 1650 | 2022-05-02 | Nuo Therapeutics, Inc. | XNAS | - | CEO | JORDEN DAVID EMERSON | direct | SOLO | 0.02 | 10 026 | 60M |
| 5 | 1650 | 2022-05-02 | Nuo Therapeutics, Inc. | XNAS | - | BOARD | Pittman Scott M. | direct | SOLO | 0.16 | 95 200 | 60M |
| 6 | 1650 | 2022-05-02 | Nuo Therapeutics, Inc. | XNAS | - | OTHER | CLAUSEN PETER | direct | SOLO | 0.04 | 23 800 | 60M |
| 7 | 1543 | 2021-06-04 | Equippp Social Impact Technologies Limited | XBOM | - | OTHER | Vivek Kumar Ratakonda | direct | SOLO | 0.00 | 58 635 | 2057M |
| 8 | 1543 | 2021-06-04 | Equippp Social Impact Technologies Limited | XBOM | - | OTHER | Equivas Capital Private Ltd | direct | SOLO | 0.05 | 1 010 330 | 2057M |
| 9 | 1543 | 2021-06-04 | Equippp Social Impact Technologies Limited | XBOM | - | OTHER | Srija Hotels & Properties Private Ltd | direct | SOLO | 0.00 | 58 635 | 2057M |
| 10 | 1386 | 2025-03-13 | CAPITAL B | XPAR | Technologie | BOARD | Ludovic Chechin-Laurans | direct | SOLO | 0.10 | 27 890 | 186M |
| 11 | 997 | 2025-05-14 | ABIVAX | XPAR | Santé & Pharma | BOARD | Dominik Hochli | direct | SOLO | - | 50 000 | 8207M |
| 12 | 959 | 2025-06-26 | ABIVAX | XPAR | Santé & Pharma | OTHER | marc de garidel thoron | direct | SOLO | 0.00 | 0 | 8207M |
| 13 | 920 | 2025-06-03 | ABIVAX | XPAR | Santé & Pharma | OTHER | marc de garidel thoron | direct | SOLO | 0.00 | 0 | 8207M |
| 14 | 821 | 2025-04-25 | ABIVAX | XPAR | Santé & Pharma | OTHER | marc de garidel thoron | direct | SOLO | 0.00 | 0 | 8207M |
| 15 | 557 | 2025-06-30 | Diös Fastigheter AB | XSTO | - | OTHER | Rolf Larsson | direct | SOLO | 1.31 | 231 357 | 18M |
| 16 | 455 | 2023-01-13 | 株式会社アースインフィニティ | XTKS | - | OTHER | Hamada Kouichi | direct | SOLO | - | 520 700 | 10132M |
| 17 | 414 | 2025-03-28 | Sound Dimension | XSTO | - | OTHER | Martin Sandberg | direct | SOLO | - | 5 244 | - |
| 18 | 379 | 2022-05-05 | GeoVax Labs, Inc. | XNAS | - | OTHER | McKee Kelly T. Jr. | direct | SOLO | 0.04 | 3 341 | 8M |
| 19 | 347 | 2022-05-06 | GeoVax Labs, Inc. | XNAS | - | OTHER | McKee Kelly T. Jr. | direct | SOLO | 0.09 | 6 641 | 8M |
| 20 | 336 | 2023-04-26 | NANOBIOTIX | XPAR | Santé & Pharma | OTHER | Laurent LEVY | direct | SOLO | - | 0 | 2240M |
| 21 | 333 | 2023-01-11 | Abalance株式会社 | XTKS | - | OTHER | Rakuten Securities, Inc. | direct | SOLO | 0.00 | - | 25593M |
| 22 | 327 | 2022-12-09 | 株式会社セルシード | XTKS | - | OTHER | Barclays Bank PLC | direct | SOLO | - | 6 396 | 9619M |
| 23 | 326 | 2022-12-19 | 株式会社アースインフィニティ | XTKS | - | OTHER | Hamada Kouichi | direct | SOLO | - | 505 287 | 10132M |
| 24 | 302 | 2021-07-07 | Aehr Test Systems | XNAS | Technologie | OTHER | Brannan Michael A. | direct | SOLO | 0.00 | 0 | 3130M |
| 25 | 302 | 2021-07-07 | Aehr Test Systems | XNAS | Technologie | CFO | SPINK KENNETH B. | direct | SOLO | 0.00 | 0 | 3130M |
| 26 | 302 | 2021-07-07 | Aehr Test Systems | XNAS | Technologie | OTHER | RICHMOND DONALD P. II | direct | SOLO | 0.00 | 0 | 3130M |
| 27 | 302 | 2021-07-07 | Aehr Test Systems | XNAS | Technologie | OTHER | Brannan Michael A. | direct | SOLO | 0.00 | 0 | 3130M |
| 28 | 302 | 2021-07-07 | Aehr Test Systems | XNAS | Technologie | CEO | Erickson Gayn | direct | SOLO | 0.00 | 0 | 3130M |
| 29 | 302 | 2021-07-07 | Aehr Test Systems | XNAS | Technologie | OTHER | RICHMOND DONALD P. II | direct | SOLO | 0.00 | 0 | 3130M |
| 30 | 302 | 2021-07-07 | Aehr Test Systems | XNAS | Technologie | OTHER | ROGERS VERNON | direct | SOLO | 0.00 | 0 | 3130M |
| 31 | 302 | 2021-07-07 | Aehr Test Systems | XNAS | Technologie | CEO | Erickson Gayn | direct | SOLO | 0.00 | 0 | 3130M |
| 32 | 302 | 2021-07-07 | Aehr Test Systems | XNAS | Technologie | CFO | SPINK KENNETH B. | direct | SOLO | 0.00 | 0 | 3130M |
| 33 | 302 | 2021-07-07 | Aehr Test Systems | XNAS | Technologie | OTHER | ROGERS VERNON | direct | SOLO | 0.00 | 0 | 3130M |
| 34 | 299 | 2021-07-23 | Globe Textiles (India) Limited | XBOM | - | OTHER | SARADABEN SURYAKANT PARIKH | direct | SOLO | 0.00 | 29 922 | 841M |
| 35 | 299 | 2021-07-23 | Globe Textiles (India) Limited | XBOM | - | OTHER | SARADABEN SURYAKANT PARIKH | direct | SOLO | 0.00 | 29 922 | 841M |
| 36 | 299 | 2021-07-23 | Globe Textiles (India) Limited | XBOM | - | OTHER | SARADABEN SURYAKANT PARIKH | direct | SOLO | 0.00 | 29 922 | 841M |
| 37 | 295 | 2025-12-05 | Medivir Aktiebolag | XSTO | - | OTHER | Fredrik Öberg | direct | SOLO | 0.00 | 3 690 | 1025M |
| 38 | 294 | 2025-07-02 | NANOBIOTIX | XPAR | Santé & Pharma | OTHER | ANNE-JULIETTE HERMANT | direct | SOLO | 0.03 | 269 500 | 2240M |
| 39 | 294 | 2025-07-02 | NANOBIOTIX | XPAR | Santé & Pharma | OTHER | ANNE-SOPHIE LARIVIERE | direct | SOLO | 0.02 | 161 600 | 2240M |
| 40 | 294 | 2025-07-02 | NANOBIOTIX | XPAR | Santé & Pharma | CFO | BARTHOLOMEUS VAN RHIJN | direct | SOLO | 0.06 | 528 351 | 2240M |
| 41 | 294 | 2025-07-02 | NANOBIOTIX | XPAR | Santé & Pharma | CEO | LAURENT LEVY | direct | SOLO | 0.17 | 1 616 937 | 2240M |
| 42 | 276 | 2025-12-03 | Medivir AB | XSTO | - | OTHER | Magnus Christensen | direct | SOLO | 0.00 | 6 026 | 1025M |
| 43 | 275 | 2022-12-27 | 株式会社セルシード | XTKS | - | OTHER | Barclays Bank PLC | direct | SOLO | - | 8 245 | 9619M |
| 44 | 275 | 2022-12-27 | 株式会社セルシード | XTKS | - | OTHER | Barclays Bank PLC | direct | SOLO | - | 7 910 | 9619M |
| 45 | 275 | 2022-12-27 | 株式会社セルシード | XTKS | - | OTHER | Barclays Bank PLC | direct | SOLO | - | 7 199 | 9619M |
| 46 | 275 | 2022-12-27 | 株式会社セルシード | XTKS | - | OTHER | Barclays Bank PLC | direct | SOLO | - | 4 861 | 9619M |
| 47 | 275 | 2022-12-27 | 株式会社セルシード | XTKS | - | OTHER | Barclays Bank PLC | direct | SOLO | - | 3 670 | 9619M |
| 48 | 275 | 2022-12-27 | 株式会社セルシード | XTKS | - | OTHER | Barclays Bank PLC | direct | SOLO | - | 7 429 | 9619M |
| 49 | 275 | 2022-12-27 | 株式会社セルシード | XTKS | - | OTHER | Barclays Bank PLC | direct | SOLO | - | 7 196 | 9619M |
| 50 | 275 | 2022-12-27 | 株式会社セルシード | XTKS | - | OTHER | Barclays Bank PLC | direct | SOLO | - | 6 625 | 9619M |
Marketing pitch angle
These 50 insider buys yielded 200%+ within 90 days post-publication. Use as social proof for retail-facing copy. Source: BacktestResult.returnFromPub90d joined to Declaration and Company. Numbers are reproducible via this script.